- STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrongCompanies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala Fakhouri says.STAT · 23d ago↗ source
- STAT+: A year after distressed buyout, what’s become of Bluebird Bio?Bluebird Bio was a dark biotech morality tale when David Meek bought it. He says the new company, Genetix, is already making money.STAT · 23d ago↗ source
- The new presidential fitness test is a positive step, not the solution, experts sayPhysical activity needs to be fun to keep kids engaged. And the test risks embarrassing them, instead.STAT · 23d ago↗ source